Cargando…
Hepatitis C and not Hepatitis B virus is a risk factor for anti-tuberculosis drug induced liver injury
BACKGROUND: The risk of anti-tuberculosis (TB) drug-induced liver injury (DILI) in patients with chronic viral hepatitis (CVH) is not clear. The aim of this study was to investigate incidence and risk factors associated with TB DILI in CVH and non-CVH patients. METHODS: Retrospectively, a total of 1...
Autores principales: | Kim, Wan Soo, Lee, Sang Soo, Lee, Chang Min, Kim, Hong Jun, Ha, Chang Yoon, Kim, Hyun Jin, Kim, Tae Hyo, Jung, Woon Tae, Lee, Ok Jae, Hong, Jeong Woo, You, Hyun Seon, Cho, Hyun Chin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4736472/ https://www.ncbi.nlm.nih.gov/pubmed/26833347 http://dx.doi.org/10.1186/s12879-016-1344-2 |
Ejemplares similares
-
Clinical features of hepatitis B and C virus infections, with high α-fetoprotein levels but not hepatocellular carcinoma
por: Kim, Cha Young, et al.
Publicado: (2017) -
Hepatitis C virus genotype affects survival in patients with hepatocellular carcinoma
por: Park, Hye Kyong, et al.
Publicado: (2019) -
Impact of acute kidney injury on survival in patients with chronic hepatitis C: a retrospective cohort study
por: Jeon, Hankyu, et al.
Publicado: (2021) -
Early monitoring for detection of antituberculous drug-induced hepatotoxicity
por: Lee, Chang Min, et al.
Publicado: (2016) -
Clinical Features and Outcomes of Patients With Genotype 3 Hepatitis C Virus Infection in Korea: A Retrospective Observational Study
por: Cha, Ra Ri, et al.
Publicado: (2016)